stockrow
Saturday 7 November 2026
Export BMGL’s income statement to Excel — free account
Basel Medical Group Ltd
BMGL Healthcare Medical Care Facilities
Basel Medical Group Ltd’s revenue for fiscal 2026 (year ended June 2026) was $12.8 million, up 43.9% from fiscal 2025.
5.25
0.06
+1.16%
Follow BMGL
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to June
| Ten-year view | Analyst estimates Powerpack | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend | 10 yrs | 2027e | 2028e | 2029e | Next 3/yr |
| Income, $m | |||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 7 | 9 | 13 | +31.4% | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | — | — | 77.63 | 77.68 | 76.06 | (1.6) pt | ||||||
| EBT | — | — | — | — | — | — | — | 2 | (10) | (1) | n/m | ||||||
| EBT margin, % | — | — | — | — | — | — | — | 23.92 | (110.47) | (7.60) | (31.5) pt | ||||||
| Net income | — | — | — | — | — | — | — | 2 | (10) | (1) | n/m | ||||||
| Per share, $ | |||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | 5.48 | 5.69 | 8.10 | +21.6% | |||||
| Earnings | — | — | — | — | — | — | — | 1.13 | (6.12) | (0.70) | n/m | ||||||
| Cash flow | — | — | — | — | — | — | — | 1.37 | (2.18) | (0.34) | n/m | ||||||
| Capex | — | — | — | — | — | — | — | 0.00 | (0.03) | (0.12) | +430.9% | ||||||
| Free cash flow | — | — | — | — | — | — | — | 1.36 | (2.21) | (0.46) | n/m | ||||||
| Book value | — | — | — | — | — | — | — | 4.12 | 2.44 | 2.22 | (26.7%) | ||||||
| Shares, m | — | — | — | — | — | — | — | 1 | 2 | 2 | +8.1% | ||||||
| Valuation, × | |||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | — | ||||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.0 | ||||||
| EV/FCF | — | — | — | — | — | — | — | 0.00 | 0.00 | (1.03) | (0.3) | ||||||
| Cash, $m | |||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | 2 | (3) | (1) | n/m | |||||
| Capex | — | — | — | — | — | — | — | 0 | 0 | 0 | +475.1% | ||||||
| Free cash flow | — | — | — | — | — | — | — | 2 | (3) | (1) | n/m | ||||||
| Balance, $m | |||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | 7 | 2 | 2 | (48.7%) | |||||
| Net debt | — | — | — | — | — | — | — | 2 | 0 | 6 | +90.8% | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | 6 | 4 | 4 | (20.7%) | ||||||
| Returns, % | |||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | 0.00 | (75.17) | (4.32) | (4.3) pt | |||||
| ROIC | — | — | — | — | — | — | — | 16.29 | (13.62) | (3.93) | (20.2) pt | ||||||
| ROE | — | — | — | — | — | — | — | 0.00 | (202.11) | (15.90) | (15.9) pt | ||||||
| People | |||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 36 | 77 | — | +113.9% | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.21 | 0.12 | 0.00 | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Jun 2026 · fundamentals updated 3 Nov 2026
Basel Medical Group Ltd vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CYH Community Health Systems, Inc. | $321.5M | 4.2× | — (loss-making) | −10.69% (below 0%: shrinking) | n/m | +857.14% (above 0%: growing) | 85.24% | 5.30% | Compare |
| JYNT The Joint Corp. | $104.2M | 25.5× | 20.1× | +14.41% (above 0%: growing) | +400.00% (above 0%: growing) | +432.31% (above 0%: growing) | 83.68% | (2.43%) | Compare |
| AIRS AirSculpt Technologies, Inc. | $103.8M | — (loss-making) | — (loss-making) | −8.71% (below 0%: shrinking) | n/m | −813.83% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| PARK Park Dental Partners, Inc. | $95.8M | — (loss-making) | — | +12.15% (above 0%: growing) | −65.84% (below 0%: shrinking) | −34.78% (below 0%: shrinking) | 14.37% | 1.90% | Compare |
| BMGL Basel Medical Group Ltd | $70.5M | — | — | — | — | — | — | — | |
| CCEL Cryo-Cell International Inc. | $39.9M | — (loss-making) | 65.1× | −0.02% (below 0%: shrinking) | +77.78% (above 0%: growing) | −58.37% (below 0%: shrinking) | 79.38% | 28.04% | Compare |
| BTMD biote Corp. | $37.4M | 6.6× | — (loss-making) | −9.48% (below 0%: shrinking) | n/m | −174.16% (below 0%: shrinking) | 65.38% | (7.93%) | Compare |
| PIII P3 Health Partners Inc. | $28.1M | — (loss-making) | — | +8.60% (above 0%: growing) | n/m | −272.24% (below 0%: shrinking) | 22.26% | 10.67% | Compare |
| DCGO DocGo Inc. | $24.1M | — (loss-making) | — (loss-making) | −8.70% (below 0%: shrinking) | n/m | −132.28% (below 0%: shrinking) | 30.52% | (24.41%) | Compare |
| Median of peers | $67.8M | 6.6× | — | −4.36% | +77.78% | −95.32% | 47.95% | 0.95% |